rabeprazole has been researched along with EBV Infections in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mannemuddhu, SS | 1 |
| Xu, H | 1 |
| Bleck, CKE | 1 |
| Tjandra, N | 1 |
| Carter, C | 1 |
| Bhaduri-McIntosh, S | 1 |
1 other study available for rabeprazole and EBV Infections
| Article | Year |
|---|---|
Prazoles Targeting Tsg101 Inhibit Release of Epstein-Barr Virus following Reactivation from Latency.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; A549 Cells; Antiviral Agents; Cell Line, Tumor; DNA-Binding | 2021 |